The cell wall of the yeast Saccharomyces cerevisiae is a tough, rigid structure, which presents a sig- nificant barrier to the release of native or recombinant proteins from this biotechnologically important organism. There is hence a need to develop inexpensive and efficient methods of lysing yeast
Genetics and biochemistry of cryptopleurine resistance in the yeast Saccharomyces cerevisiae
✍ Scribed by Sánchez, L. ;Vásquez, D. ;Jiménez, A.
- Publisher
- Springer
- Year
- 1977
- Tongue
- English
- Weight
- 725 KB
- Volume
- 156
- Category
- Article
- ISSN
- 0026-8925
No coin nor oath required. For personal study only.
✦ Synopsis
Protein synthesis by ribosomes from several cryptopleurine-resistant yeast mutants is also resistant to emetine and tubulosine. These mutants can be classified into two different types: Class I mutants which display high levels of resistance to emetine and tubulosine and Class II mutants that are only weakly resistant to tubulosine and are slightly more sensitive to emetine than those of Class I. Apparently all mutants have similar levels of resistance to cryptopleurine. The distinct phenotypes of Class I and Class II strains are expressed through their 40S ribosomal subunit. Genetic analysis has shown that the mutations to cryptopleuring resistance are allelic and that in a particular case (strain CRY6) the pleiotropic phenotype is a result of the expression of the cry1 locus. It is suggested that Class I and Class II mutants arise from two independent mutational events within The cry1 allel. In heterozygous (+/cry1) diploids both the sensitive and the resistant genes are expressed as shown by studies of the action of cryptopleurine on polyphenylalanine-synthesizing systems derived from each parental sensitive and resistant haploid strain and heterozygous diploid strains. The apparent dominance of sensitivity over resistance which may be observed in vivo in heterozygous (+/cry1) diploids has been explained in terms of the mode of action of the inhibitors.
📜 SIMILAR VOLUMES
Axenomycin inhibits protein synthesis in vivo and in vitro in Saccharomyces cerevisiae. The antibiotic acts by binding to ribosomes, most probably to the large ribosomal subunit. Mutant strains resistant to axenomycin appear to contain ribosomes that are not inhibited by the antibiotic. The responsi
Mter a short introduction on the historical background of the development of Saccharomyces cere&iae as a model eukaryote, a review is given on the present state of genetics and molecular biology of copper resistance in 5. cereviaiae. The gene CUPl encodes a protein (copper metallothionein) of a mole